Triglav Skladi’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21M Sell
63,907
-30,208
-32% -$9.43M 1.08% 22
2026
Q2
$40.8M Buy
94,115
+53,895
+134% +$16.4M 2.15% 14
2026
Q1
$8.59M Buy
40,220
+35,220
+704% +$7.87M 0.6% 34
2025
Q4
$856K Hold
5,000
– – 0.05% 140
2025
Q3
$670K Hold
5,000
– – 0.04% 130
2025
Q2
$487K Hold
5,000
– – 0.04% 124
2025
Q1
$364K Sell
5,000
-9,750
-66% -$768K 0.03% 126
2024
Q4
$1.07M Buy
+14,750
New +$1.12M 0.08% 103

Other funds holding LRCX

Triglav Skladi's LRCX Position: Q3 2026 in Review

Triglav Skladi reduced its Lam Research (LRCX) stake by 32% in Q3 2026, selling an estimated $9.43M and leaving 63,907 shares worth $21M. The position accounts for 1.08% of the portfolio, ranked #22.

Triglav Skladi first reported a position in LRCX in Q4 2024 and has held it in 8 quarters since. The position peaked at $40.8M in Q2 2026. 2,966 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Triglav Skladi held 63,907 shares of Lam Research worth $21M as of Q3 2026.
  • Triglav Skladi sold 30,208 Lam Research shares in Q3 2026, an estimated $9.43M.
  • Lam Research made up 1.08% of Triglav Skladi's portfolio in Q3 2026, its #22 holding.
  • Triglav Skladi first reported a position in Lam Research in Q4 2024 and has held it in 8 quarters since.
  • Triglav Skladi's Lam Research position peaked at $40.8M in Q2 2026.
  • 2,966 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Triglav Skladi's 13F filing for Q3 2026, filed 6 Nov 2026.